NCT05080049 (EPO-ICU-FS) is a Phase 3 clinical trial of Erythropoietin in Anemia, sponsored by University Hospital, Angers.

Who is sponsoring NCT05080049?

NCT05080049 is sponsored by University Hospital, Angers.

What drugs are being tested in NCT05080049?

Interventions in NCT05080049: Erythropoietin, Placebo.

What condition does NCT05080049 study?

NCT05080049 studies Anemia, Intensive Care.

Is NCT05080049 still recruiting?

NCT05080049 is currently status unknown. Last updated 10 October 2022.

Last reviewed 2022-10-10 · How we verify

NCT05080049: EPO-ICU-FS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Erythropoietin to Improve Critical Care Patient Outcomes

Status unknown Phase 3 Last updated 10 October 2022

What this trial tests

Phase 3 trial testing Erythropoietin in Anemia in 42 participants. Status unknown.

Timeline

28 January 2022

Primary endpoint
2 September 2022

31 December 2022

Quick facts

Lead sponsor	University Hospital, Angers
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	42
Start date	28 January 2022
Primary completion	2 September 2022
Estimated completion	31 December 2022
Sites	2 locations across France

Drugs / interventions tested

Erythropoietin — full drug profile →
Placebo

Conditions studied

Anemia — all drugs for Anemia →
Intensive Care — all drugs for Intensive Care →

Sponsor

University Hospital, Angers

Who can join

18 and older, any sex, with Anemia or Intensive Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recently, the french societies for critical care (SFAR and SRLF) produced guidelines for anemia treatment in critically ill patients that recommend the use of erythropoietin (EPO) in these patients, but the european society (ESICM) recommended against the use of EPO in this patients, despite recent meta analysis showing a lower mortality in patients treated with EPO. Nevertheless, RCT on EPO in the ICU are quite all, new data are thus needed. Before conducting a large study on EPO in anemic patients in the ICU, we propose to cinduct a feasability RCT to evaluate the feasability of such a study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erythropoietin

Trials testing the same drug.

NCT06983756 — " Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Out · not yet recruiting
NCT06590155 — Erythropoietin in HIE Neonate · EARLY_PHASE1 · not yet recruiting
NCT06542393 — PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) · Phase 2 · recruiting
NCT05395195 — Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) · Phase 3 · recruiting
NCT05300477 — Pharmacological Countermeasures for High Altitude · Phase 4 · active not recruiting

Other recruiting trials for Anemia

Currently open trials in the same condition.

NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting

Other University Hospital, Angers trials

Trials by the same sponsor.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07470294 — Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Popula · not yet recruiting
NCT07409597 — Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease · NA · not yet recruiting
NCT07468565 — Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) · not yet recruiting
NCT07452952 — Relationship Between the Level of Positive End-expiratory Pressure and Venous Congestion During Acute Respiratory Distre · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05080049 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Angers
Last refreshed: 10 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05080049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing